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Feline leukaemia virus (FeLV) infection in felids results mainly from oronasal exposure 12
to infectious saliva and nasal secretions, but the potential for viral transmission through 13
faeces and urine has not been completely characterized. In order to assess and14
compare potential FeLV transmission routes, we determined the viral kinetics in 15
plasma, saliva, faeces and urine during early experimental FeLV infection (up to week 16
15 post exposure) in specific pathogen-free cats. In addition to monitoring p27 antigen 17
levels measured by ELISA, we evaluated the presence of infectious particles by cell 18
culture assays and quantified viral RNA loads by a quantitative real-time TaqMan 19
polymerase chain reaction RNA load was associated with infection outcome (high load 20
– progressive infection; low load – regressive infection) not only in plasma, but also in 21
saliva, faeces and urine. Infectious virus was isolated from the saliva, faeces and urine 22
of infected cats with progressive infection as early as three to six weeks post-infection, 23
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but usually not in cats with regressive infection. In cats with progressive infection, 24
therefore, not only saliva but also faeces and to some extent urine might represent 25
potential FeLV transmission routes. These results should be taken into account when 26
modelling FeLV-host interactions and assessing FeLV transmission risk. Moreover, 27
during early FeLV infection, detection of viral RNA in saliva may be used as an indicator 28
of recent virus exposure, even in cats without detectable antigenaemia/viraemia. To 29
determine the clinically relevant outcome of FeLV infection in exposed cats, however, 30
p27 antigen levels in the peripheral blood should be measured. (250 words)31
32
Keywords: feline leukaemia virus; real-time TaqMan® reverse transcriptase 33
polymerase chain reaction; pathogenesis; retrovirus; virus-host interaction; viral loads; 34
virus kinetics; virus shedding.35
36
Introduction37
Feline leukaemia virus (FeLV) is a gammaretrovirus of felids, and is not only of interest 38
for veterinary practice, but is also an important model for tumour and AIDS research 39
(Miyazawa, 2002; Onions, 1985). FeLV-host relationships were revaluated recently 40
using sensitive real-time PCR methods and categorized with respect to proviral and 41
plasma viral RNA load in the peripheral blood of infected cats, and also based on the 42
presence or absence of virus in the blood and bone marrow as well as antigenaemia 43
(Hofmann-Lehmann et al., 2008; Hofmann-Lehmann et al., 2006; Torres et al., 2005). 44
Five putative categories were suggested; designated abortive infection (no detectable 45
provirus, viral RNA or antigen subsequent to viral exposure), regressive infection with46
undetectable antigenaemia, regressive infection with transient antigenaemia, latent 47
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infection, and progressive infection characterized by persistent antigenaemia and 48
positive virus isolation (Cattori et al., 2006; Hofmann-Lehmann et al., 2008; Hofmann-49
Lehmann et al., 2007; Torres et al., 2005). In the latter four categories, all cats were 50
found to become positive for provirus and viral RNA, and the loads had a significant 51
association with infection outcome (Hofmann-Lehmann et al., 2006).52
The intra-host kinetics of FeLV were characterized 30 years ago using non-molecular 53
techniques (Francis and Essex, 1977). The virus was found to initially target local 54
lymphoid tissues, where it infects lymphocytes and monocytes, causing a primary cell-55
associated viraemia that expands to the lymphoid tissues of the whole body within 56
approximately two weeks. Neutrophil and platelet precursors in the bone marrow and 57
small intestine crypt cells are infected within three weeks. This leads to a second cell-58
associated viraemia, including infection of circulating neutrophils and platelets starting 59
from weeks two through four post-infection and excretion in mucosal and gland tissues 60
from weeks four through eight post-infection (Rojko et al., 1979). The more recent 61
development of sensitive FeLV-specific quantitative PCR assays has allowed the 62
determination of proviral and plasma viral RNA loads in FeLV exposed cats and, 63
therefore, the study of cats with undetectable antigenaemia and viraemia (Hofmann-64
Lehmann et al., 2001; Tandon et al., 2005; Torres et al., 2005). Viral and proviral loads 65
were proposed to be implicated in the outcome of FeLV infection very early, but not 66
prior to week one post-FeLV exposure (Hofmann-Lehmann et al., 2001; Hofmann-67
Lehmann et al., 2006). Nonetheless, the relationship between plasma viral loads and 68
the potential shedding routes for FeLV has not yet been investigated. 69
In mathematical models of the interactions between pathogens and the immune 70
response of the host, the parameters for the epidemiological spread of disease can be 71
estimated from the intra-host dynamics, e.g., the variation in viral load or the 72
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mechanism of pathogenesis (Ganusov et al., 2002). Thus, knowledge of intra-host viral 73
load kinetics and potential transmission routes is essential to fully understand the 74
epizootiology and virulence evolution potential of FeLV in infected animals. In this 75
context, saliva (as the primary source), blood and faeces have been identified as FeLV 76
transmission routes (Francis and Essex, 1977; Gomes-Keller et al., 2006a), but the 77
shedding kinetics during the early phase of the infection and the role played by urine in 78
this context are unknown thus far. Therefore, the goals of the present study were 1) to 79
estimate the transmission potential of FeLV via urine from FeLV-infected cats by 80
measuring the FeLV loads and kinetics in this compartment, and 2) to compare it with 81
those of the saliva and faeces from these same cats, as well as with those in the 82
peripheral blood during the early phase of infection (first 15 weeks). We studied cats 83
with both regressive and progressive infection. FeLV loads were determined using 84
FeLV antigen detection, virus isolation to measure replicating virus and molecular 85
methods for sensitive detection of viral RNA.  86
Materials and methods87
Ten 18-week-old outbred, specific pathogen-free (SPF) domestic kittens (Liberty 88
Research Laboratory, Waverly, NY, USA) were infected intraperitoneally with 5 × 10589
focus forming units of FeLV-A/Glasgow-1 (week 0). Six SPF cats of the same age and 90
origin served as negative controls. The cats were housed in two groups in separate 91
rooms in accordance with the Swiss federal research animal care regulations. Blood 92
samples were drawn weekly from week 0 to 15. Saliva specimens were collected in 93
triplicate with the aid of cotton wool swabs three times per week for the first four weeks 94
and weekly thereafter, and faecal specimens were collected in the same way at weeks 95
0 through 3 and weeks 6, 9, 12 and 15. Two swabs were placed in 1.5 ml 96
microcentrifuge tubes and stored at -80 °C until further processing. The third swab was 97
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placed in a 1.5 ml microcentrifuge tube containing 500 µl RPMI medium (Sigma) 98
supplemented with 10% heat-inactivated fetal calf serum (Bioconcept, Allschwil, 99
Switzerland), 2 mM L-glutamine (Invitrogen, Basel, Switzerland) and 400 IU/ml 100
penicillin-streptomycin (Invitrogen). The swabs were inverted, and the tubes were 101
centrifuged at 8,000Χg for 3 min. The swabs were then discarded, and the medium was 102
stored at -80 °C for virus isolation. Sterile urine samples were collected by 103
cystocentesis at weeks 3, 6, 9, 12 and 15.104
Viral RNA in all samples was quantified by real-time TaqMan reverse transcriptase 105
(RT)-PCR (Tandon et al., 2005); FeLV antigenaemia was measured by p27 sandwich 106
ELISA (Lutz et al., 1983); and the presence of infectious FeLV was determined by virus 107
isolation on QN10S cells (Jarrett and Ganiere, 1996) and testing of cell culture 108
supernatants for the presence of replicating FeLV by p27 ELISA or RT-PCR (Gomes-109
Keller et al., 2006b). For p27 ELISA, results were calculated as the percentage of a 110
positive control, which was assayed with every plate. Values above 4% were 111
considered positive. In addition, virus neutralizing antibody titres were determined in 112
plasma samples by focus reduction assays using FeLV-A/Glasgow-1 on QN10S cells 113
(Jarrett and Ganiere, 1996). 114
For RT-PCR, nucleic acids were extracted from 140 μl of sterile EDTA-anticoagulated 115
plasma (QIAamp Viral RNA Mini Kit (Qiagen, Hombrechtikon, Switzerland) or 200 μl of 116
sterile urine (MagNA Pure® LC Total Nucleic Acid Isolation Kit, Roche, Basel, 117
Switzerland). For faecal and saliva specimens, two swabs from each sample were used 118
for nucleic acid extraction and ELISA as follows: 200 μl of HBSS (Hank's Balanced Salt 119
Solution, without calcium chloride, magnesium chloride, and magnesium sulphate, 120
GIBCO, Paisley, Scotland, UK) was pipetted into the tubes, which were vortexed, 121
incubated at 42 °C for 10 min and centrifuged at 8,000Χg for 1 min. The swabs were 122
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inverted, and the tubes centrifuged again at 8,000Χg for 1 min. The swabs were then 123
discarded, and the tubes centrifuged again to pellet the cells and impurities. The 124
eluates from duplicate samples were pooled, and the volume was adjusted to 400 µl 125
with HBSS. An aliquot of 200µl was used for RNA extraction (MagNA Pure® LC Total 126
Nucleic Acid Isolation Kit, Roche), and 200 µl were used for p27 ELISA after the 127
addition of 50 μl of a solution of two monoclonal antibodies specific for p27 (Lutz et al., 128
1983) diluted 1:50 in 0.75 M sodium chloride, 5 mM EDTA disodium salt, 250 mM Tris-129
Base, 0.5% Tween20 and 0.5% bovine serum albumin (all reagents from Sigma, Buchs, 130
Switzerland).131
Statistical analysis of the data was performed using GraphPad Prism (version 3.0, 132
GraphPad Software, San Diego, CA, USA). 133
Results  134
Five out of ten FeLV challenged cats developed a progressive infection as judged by 135
persistently positive p27 ELISA results, virus isolation from plasma and the absence of 136
virus neutralizing activity. Five cats developed a regressive infection. One of the cats 137
with a regressive infection showed transient antigenaemia, and four had undetectable 138
antigenaemia (Table 1 and Fig. 1e). The latter five cats produced virus neutralizing 139
antibodies starting at week 6 after virus exposure (Table 1). In cats with progressive 140
infection, viral RNA was detectable before FeLV p27 antigen in all four investigated 141
compartments (Fig. 1). In plasma and saliva, viral RNA was found as early as one week 142
post-infection, while p27 ELISA was only positive starting at week three. In faeces, 143
FeLV RNA and p27 appeared approximately one week later: RT-PCR was positive from 144
week two on, and p27 became detectable in week four. For animal welfare reasons, 145
urine samples were collected only every three weeks. In week three, FeLV RNA was 146
readily detectable in urine. All ELISA results from urine samples were negative 147
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throughout the observation period. In virus isolation, a similar sequence of appearance 148
was observed in the four investigated compartments: in plasma, all cats with 149
progressive infection were positive at week three (first time point investigated), while 150
only one out of five animals tested positive in saliva. All saliva and faeces samples from 151
cats with progressive infection were virus isolation positive at week six, while the 152
majority of the urine samples became positive at week nine after virus exposure.153
Interestingly, the cats with regressive infection were also found to be viral RNA positive, 154
at least transiently, in all investigative compartments. In order to detect a potential 155
association between the outcome of infection and viral RNA loads in saliva, plasma, 156
faeces and urine, the cats were grouped according to their infection outcome and their 157
loads were compared. The Cats with progressive infection had significantly higher 158
plasma viral RNA loads than the cats with regressive infection starting at week two 159
post-infection (Mann-Whitney U-test: pMWU < 0.05). Faecal and saliva loads were 160
higher from week three post-infection onward (both pMWU < 0.05), and urine loads 161
were higher starting at week six post-infection (pMWU < 0.01) in the cats with 162
progressive infection compared to cats with regressive infection. Virus isolation and p27 163
ELISA were negative in the saliva, faeces and urine of the cats with regressive 164
infection, with one exception where the sample showed a weak signal.165
Comparison of viral RNA loads among different compartments was only possible in 166
samples collected quantitatively (e.g., plasma and urine samples). Plasma RNA loads 167
were not significantly different from urine RNA loads in either the cats with progressive 168
or the cats with regressive infection (Wilcoxon Signed Rank Test: pW > 0.05). 169
Nevertheless, a tendency was found in weeks 3, 6, 9 and 15 post-infection in the cats 170
with progressive infection in that plasma viral RNA loads were somewhat higher than 171
urine RNA loads (pW=0.0625).172
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173
Discussion174
The best recognized natural route of FeLV infection is oronasal exposure of naïve cats 175
to the saliva and nasal secretions of infected cats. The potential for transmission via 176
other routes such as faeces or urine had been incompletely characterized prior to this 177
study, and shedding kinetics had not been investigated. The data presented here 178
assess and compare for the first time the viral kinetics of FeLV throughout early 179
infection in four different compartments – plasma, saliva, faeces and urine – in cats with 180
regressive and progressive infection outcomes. By using real-time RT-PCR for the 181
quantification of viral RNA and cell culture techniques for the detection of infectious 182
virus, we demonstrate that not only saliva and faeces, but also urine can bear viral RNA 183
and infectious FeLV particles. These findings are important in light of inter-host 184
modelling of FeLV infection: faeces and urine are additional potential transmission 185
routes for FeLV and must be considered when modelling cat-to-cat FeLV transmission. 186
With one exception, infectious virus particles were only found in the plasma, saliva, 187
faeces and urine of cats with progressive infection. This is in accordance with a 188
previous study investigating mostly cats with progressive infection one year after189
experimental FeLV exposure (Gomes-Keller et al., 2006b), in which infectious particles 190
were only found in saliva samples from cats with progressive FeLV infection. This is 191
important with respect to the transmission potential of FeLV in infected cats: cats with 192
progressive infection can shed infectious virus to the environment through their saliva, 193
and can therefore infect other cats by mutual grooming and sharing of eating and 194
drinking bowls (Francis and Essex, 1977). Our results demonstrate that faeces and, to 195
a lesser extent, urine can also be considered to be potential routes of FeLV 196
transmission. To our knowledge, this is the first study to demonstrate that infectious 197
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virus is also shed via the urine of cats with progressive infection. In accordance with the 198
saliva results, only cats with progressive infection, not those with regressive infection, 199
were found to shed infectious particles in the urine and faeces. Thus, we suspect that 200
FeLV might also be transmitted via contact with urine and sharing of litter boxes. So far, 201
the infection risk via faeces and urine can only be estimated: while FeLV loads in 202
faeces are relatively high, indicating a high potential for transmission, FeLV loads in 203
urine were somewhat lower and might pose a lower risk of infection. However, further 204
experiments (e.g., in vivo transmission) must be performed in order to confirm the 205
potential of FeLV transmission through these two compartments.206
We found infectious FeLV in saliva at the first time points investigated – three to six 207
weeks after virus exposure. Thus, cats undergoing progressive infection may shed 208
infectious virus via their saliva even at the earliest time point at which the routine 209
diagnostic test for FeLV, detection of plasma p27, typically yields a positive result 210
(Tandon et al., 2005). We speculate that prior to week three, saliva samples would have 211
been negative for virus isolation. Four out of five samples collected from cats with 212
progressive infection in week three were still negative. This assumption would be in 213
accordance with results from Rojko and co-workers, who have demonstrated that the 214
infection of mucosal and glandular epithelial tissues and, in turn, the excretion of FeLV 215
usually starts approximately four weeks after infection, subsequent to bone marrow 216
infection and secondary viraemia in neutrophils and platelets around week three (Rojko 217
et al., 1979). The latter viraemia is presumably associated with the spread of the virus 218
to other compartments. FeLV compartmental kinetics in the present study also followed 219
this scheme: infectious virus appeared first in the plasma and subsequently in saliva, 220
faeces and urine (following the granulocyte-monocyte phase). This was also evident 221
when considering the association between infection outcome and viral RNA loads: in all 222
compartments, cats with progressive infection had significantly higher loads than cats 223
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with regressive infection. The loads started to differ at different time points; i.e., the 224
difference was first found in plasma, and only later in saliva, faeces and urine. The use 225
of a sensitive real-time RT-PCR assay allowed the assessment of FeLV shedding even 226
in the urine of cats with regressive infection and undetectable antigenaemia/viraemia, 227
which had not previously been possible using non-molecular assays. The concentration 228
of RNA that could be found in urine, however, was somewhat lower than in plasma, 229
indicating that a widespread infection of the kidney and urinary tract did not occur in the 230
first four months post-infection.231
During early infection, viral RNA was detectable in cats with progressive and regressive 232
infection, not only in plasma as described previously (Hofmann-Lehmann et al., 2001; 233
Hofmann-Lehmann et al., 2006), but also in saliva, and to some extent in faeces and 234
urine. Since four out of the five cats with regressive infection had undetectable 235
antigenaemia/viraemia during the investigated period up to week 15 after virus 236
exposure, they would not have been categorized as FeLV-infected using non-molecular 237
assays. Nonetheless, these four cats were clearly infected with FeLV: they were plasma 238
viral RNA positive for weeks and developed virus-neutralizing antibodies. Thus, during 239
the investigated period up to 15 weeks after FeLV exposure, saliva viral RNA did not 240
seem to be a marker for antigenaemia/viraemia as had been demonstrated for long-241
term infected cats, i.e., cats infected with FeLV for one year (Gomes-Keller et al., 242
2006b). Therefore, p27 antigen detection performed on repeated occasions still 243
appears to be the method of choice to determine the outcome of FeLV infection during 244
the early phase of infection investigated here. The outcome of FeLV infection is of 245
clinical importance since cats with progressive infection usually succumb to FeLV 246
associated diseases (McClelland et al., 1980). Nevertheless, testing for viral RNA in 247
saliva could provide insight into possible recent exposure to FeLV, especially in the 248
absence of detectable p27 antigen in the peripheral blood.249
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In conclusion, these results indicate that urine, in addition to saliva and faeces, is an 250
additional potential means for FeLV transmission. We also show that FeLV shedding 251
via saliva, faeces and urine is subject to different kinetics during the early phase of 252
infection. These parameters must be taken in account in epidemiological models and 253
can be used to assess the risk that infected cats may pose to naïve cats. Moreover, 254
these results demonstrate that during early FeLV infection, detection of viral RNA in 255
saliva is a more sensitive marker of recent virus exposure than p27 detection in the 256
peripheral blood. The latter, however, is still the diagnostic method of choice to 257
determine the outcome of FeLV infection in exposed cats.258
259
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Figure legend321
Figure 1. Viral RNA (a-d) and p27 (e-g) loads in plasma (a,e), saliva (b,f), faeces (c,g) 322
and urine (d,h) in experimentally FeLV-infected cats. Closed symbols and continuous 323
lines represent data from cats with progressive infection (plasma p27-positive from 324
onset to week 15); open symbols and broken lines indicate data from cats with 325
regressive infection.  =cat B8; ■=cat L2; ▲=cat M1; ●=cat Y3; ж=cat Y4; ○=cat A6; 326
x=cat A7; ∆=cat J1; □=cat K5; ◊=cat Y2. Weeks post-infection are represented on the 327
X-axes. Y-axes represent the log10 RNA copies/15 µl for plasma (a) and urine (d); 328
log10 RNA copies/100 µl swab eluate for saliva (b) and faeces (c); or the percentage 329
obtained by p27 ELISA in comparison to a positive control that was considered to be 330
100% (e-h). 331
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Table 1. Virus isolation from different compartments and viral neutralising antibodies at weeks 3, 6, 9, 12 and 15 post-infection in 332
experimentally infected SPF cats. 333
Cata Week 3 Week 6 Week 9 Week 12 Week 15
NA b Virus isolation c NA Virus isolation NA Virus isolation NA Virus isolation NA Virus isolation
PL SA FE UR PL SA FE UR PL SA FE UR PL SA FE UR PL SA FE UR
B8 - ♦ ● □   ∆ - ♦ ● ■ ▲d - ♦ ● ■ ▲d - ♦ ● ■ ▲ - ♦ ● ■   ∆
L2 - ♦ ○ □   ∆ - ♦ ● ■   ∆ - ♦ ● ■   ∆ - ♦ ● ■ ▲d - ♦ ● ■ ▲
M1 - ♦ ○ □   ∆ - ♦ ● ■   ∆ - ♦ ● ■ ▲d - ♦ ● ■ ▲d - ♦ ● ■ ▲d
Y3 - ♦ ○ □   ∆ - ♦ ● ■   ∆ - ♦ ● ■ ▲d - ♦ ● ■   ∆ - ♦ ● ■ ▲
Y4 - ♦ ○ □   ∆ - ♦ ● ■   ∆ - ♦ ● ■ ▲ - ♦ ● ■ ▲d - ♦ ● ■ ▲
A6 - ◊ ○ □   ∆ + ◊ ○ □   ∆ ++ ◊ ○ □   ∆ +++ ◊ ○ □   ∆ +++ ◊ ○ □   ∆
A7 - ◊ ○ □   ∆ + ◊ ○ □   ∆ +++ ◊ ○ □   ∆ +++ ◊ ○ □   ∆ +++ ◊ ○ □   ∆
J1 - ◊ ○ □   ∆ ++ ◊ ○ □   ∆ +++ ◊ ○ □   ∆ +++ ◊ ○ □   ∆ +++ ◊ ○ □   ∆
K5 - ◊ ○ □   ∆ ++ ◊ ○ □   ∆ +++ ◊ ○ □   ∆ +++ ◊ ○ □   ∆ +++ ◊ ○ □   ∆
Y2 - ◊ ○ □   ∆ + ◊ ○ □   ∆ ++ ◊ ○ □   ∆ ++ ◊ ○ ■d   ∆ ++ ◊ ○ □   ∆
a B8, L2, M1, Y3, Y4: cats with progressive infection (plasma p27-positive from onset to week 15). A6, A7, K5, J1, Y2: cats with regressive 334
infection.335
b NA: neutralizing antibodies: –: absence of NA, +: presence of NA, titre of 8, ++: titre of 16, +++:  titre of 32.336
c Virus isolation; open symbols: negative result, closed symbols: positive result. PL: plasma, SA: saliva, FE: faeces, UR: urine. 337
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d Low copy number: RT-PCR positive but with copy numbers lower than those of the last positive RNA standard controls. Virus replication in 338
these samples is either confined to a few cells or is minimal.339
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